Open Innovation in Drug Development
The Express Pharma website reported that the complexities involved in commercializing any new drug has led pharma companies to adopt a more open, collaborative approach for their research and development processes. There are several advantages to introducing open innovation for the drug creation process. Open innovations and collaborations have managed
Comments Off on Open Innovation in Drug Development • Read this story »
More Articles
Bayer Launches Open Innovation Challenge
The Nation website reported that Bayer Pharmaceuticals is addressing the problem of drug adherence in the elderly by launching the “Grants4sApps” challenge in Singapore. The Grants4Apps Bayer-NUS Open Innovation Challenge calls for innovative health tech solutions across countries in Asia-Pacific
Comments Off on Bayer Launches Open Innovation Challenge • Read this story »
Chesbrough on Open Innovation in Life Sciences
The journal Nature published an interview with Henry Chesbeough. The article noted that open innovation has taken the business world by storm. In his 2003 breakout book, Chesbrough argued — based largely on observations of the computer industry — that companies need to look beyond their walls
Comments Off on Chesbrough on Open Innovation in Life Sciences • Read this story »
Social Innovation in Pharma
An article on the pmlive website noted that we tend to judge how well pharmaceutical companies are doing in social media by analyzing their presence on Facebook, Twitter and YouTube. But there are many other ways of using social media that should be added to the equation, including the use of what is
Comments Off on Social Innovation in Pharma • Read this story »
Open Innovation in Pharma
The PharmExecBlog notes that there are a number of highly innovative US companies that were at one time fully-integrated entities — companies that made mainframe computers, wrote the software, and sold you the paper on which to print. Essentially, they did everything from soup to nuts. That model
Winds of Open Innovation in Pharma
In a post on the lillycoi website Tom Krohn notes “the diversity of ways open innovation is manifested. While some seem to criticize that ‘everything is now open innovation’ I’ve come to appreciate the diversity. To me it isn’t about what it is called, but rather what it